Cited by 188

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity

Guerau-de-Arellano, Mireia, Smith, Kristen M., Godlewski, Jakub, Liu, Yue, Winger, Ryan, Lawler, Sean E., Whitacre, Caroline C., Racke, Michael K., Lovett-Racke, Amy E.·2011·Brain

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awr262

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Alevizos, 2010, MicroRNAs as biomarkers in rheumatic diseases, Nat Rev Rheumatol, 6, 391, 10.1038/nrrheum.2010.81 · DOI
  2. Allegretta, 1990, T cells responsive to myelin basic protein in patients with multiple sclerosis, Science, 247, 718, 10.1126/science.1689076 · DOI
  3. Annunziata, 2003, High frequency of psoriasis in relatives is associated with early onset in an Italian multiple sclerosis cohort, Acta Neurol Scand, 108, 327, 10.1034/j.1600-0404.2003.00158.x · DOI
  4. Balashov, 1997, Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand, Proc Natl Acad Sci USA, 94, 599, 10.1073/pnas.94.2.599 · DOI
  5. Baranzini, 2009, Pathway and network-based analysis of genome-wide association studies in multiple sclerosis, Hum Mol Genet, 18, 2078, 10.1093/hmg/ddp120 · DOI · Paper page
  6. Baranzini, 2009, Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis, Hum Mol Genet, 18, 767, 10.1093/hmg/ddn388 · DOI · Paper page
  7. Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  8. Bergamaschi, 2009, Inverse relationship between multiple sclerosis and allergic respiratory diseases, Neurol Sci, 30, 115, 10.1007/s10072-009-0036-8 · DOI
  9. Boettger, 2009, Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster, J Clin Invest, 119, 2634, 10.1172/JCI38864 · DOI
  10. Compston, 2008, Multiple sclerosis, Lancet, 372, 1502, 10.1016/S0140-6736(08)61620-7 · DOI
  11. Couturier, 2011, Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility, Brain, 134, 693, 10.1093/brain/awr010 · DOI
  12. Cox, 2010, MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood, PLoS One, 5, e12132, 10.1371/journal.pone.0012132 · DOI
  13. Crawford, 2004, High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay, Blood, 103, 4222, 10.1182/blood-2003-11-4025 · DOI
  14. Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038/nrg2634 · DOI
  15. De Jager, 2009, Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci, Nat Genet, 41, 776, 10.1038/ng.401 · DOI · Paper page
  16. De Santis, 2010, Altered miRNA expression in T regulatory cells in course of multiple sclerosis, J Neuroimmunol, 226, 165, 10.1016/j.jneuroim.2010.06.009 · DOI
  17. Du, 2009, MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis, Nat Immunol, 10, 1252, 10.1038/ni.1798 · DOI · Paper page
  18. Ebers, 2008, Environmental factors and multiple sclerosis, Lancet Neurol, 7, 268, 10.1016/S1474-4422(08)70042-5 · DOI
  19. Eletto, 2008, Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a, J Cell Physiol, 216, 764, 10.1002/jcp.21452 · DOI
  20. Evangelisti, 2009, MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness, FASEB J, 23, 4276, 10.1096/fj.09-134965 · DOI · Paper page
  21. Ferracin, 2010, Micromarkers: miRNAs in cancer diagnosis and prognosis, Expert Rev Mol Diagn, 10, 297, 10.1586/erm.10.11 · DOI
  22. Frohman, 2006, Multiple sclerosis–the plaque and its pathogenesis, N Engl J Med, 354, 942, 10.1056/NEJMra052130 · DOI
  23. Giegerich, 1992, Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes, Eur J Immunol, 22, 753, 10.1002/eji.1830220319 · DOI
  24. Godlewski, 2008, Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal, Cancer Res, 68, 9125, 10.1158/0008-5472.CAN-08-2629 · DOI · Paper page
  25. Goverman, 1993, Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity, Cell, 72, 551, 10.1016/0092-8674(93)90074-Z · DOI
  26. Guidi, 2010, Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells, BMC Mol Biol, 11, 95, 10.1186/1471-2199-11-95 · DOI
  27. Hosokawa, 2006, Regulation of Th2 cell development by Polycomb group gene bmi-1 through the stabilization of GATA3, J Immunol, 177, 7656, 10.4049/jimmunol.177.11.7656 · DOI
  28. Junker, 2009, MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47, Brain, 132, 3342, 10.1093/brain/awp300 · DOI · Paper page
  29. Karni, 1999, Association of MS with thyroid disorders, Neurology, 53, 883, 10.1212/WNL.53.4.883 · DOI
  30. Keller, 2009, Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls, PLoS One, 4, e7440, 10.1371/journal.pone.0007440 · DOI
  31. Lindberg, 2010, Altered expression of miR-17–5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients, Eur J Immunol, 40, 888, 10.1002/eji.200940032 · DOI
  32. Lock, 2002, Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis, Nat Med, 8, 500, 10.1038/nm0502-500 · DOI
  33. Lovett-Racke, 1998, Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells, J Clin Invest, 101, 725, 10.1172/JCI1528 · DOI
  34. Nielsen, 2006, Type 1 diabetes and multiple sclerosis: a Danish population-based cohort study, Arch Neurol, 63, 1001, 10.1001/archneur.63.7.1001 · DOI
  35. Oksenberg, 2010, Multiple sclerosis genetics-is the glass half full, or half empty?, Nat Rev Neurol, 6, 429, 10.1038/nrneurol.2010.91 · DOI
  36. Olsson, 1990, Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma, J Clin Invest, 86, 981, 10.1172/JCI114800 · DOI
  37. Otaegui, 2009, Differential micro RNA expression in PBMC from multiple sclerosis patients, PLoS One, 4, e6309, 10.1371/journal.pone.0006309 · DOI
  38. Pedersen, 2007, Interferon modulation of cellular microRNAs as an antiviral mechanism, Nature, 449, 919, 10.1038/nature06205 · DOI
  39. Pedotti, 2009, Allergy and multiple sclerosis: a population-based case-control study, Mult Scler, 15, 899, 10.1177/1352458509106211 · DOI
  40. Pelfrey, 2000, Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production, J Immunol, 165, 1641, 10.4049/jimmunol.165.3.1641 · DOI
  41. Roquer, 1987, Multiple sclerosis and Hashimoto's thyroiditis, J Neurol, 234, 23, 10.1007/BF00314004 · DOI
  42. Rosati, 2001, The prevalence of multiple sclerosis in the world: an update, Neurol Sci, 22, 117, 10.1007/s100720170011 · DOI
  43. Sloka, 2002, Observations on recent studies showing increased co-occurrence of autoimmune diseases, J Autoimmun, 18, 251, 10.1006/jaut.2002.0588 · DOI
  44. Tadesse, 2005, Bayesian error-in-variable survival model for the analysis of GeneChip arrays, Biometrics, 61, 488, 10.1111/j.1541-0420.2005.00313.x · DOI
  45. Tzartos, 2008, Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis, Am J Pathol, 172, 146, 10.2353/ajpath.2008.070690 · DOI
  46. Windhagen, 1998, Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis, J Neuroimmunol, 91, 1, 10.1016/S0165-5728(98)00086-1 · DOI
  47. Wu, 2010, Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region, Oncogene, 29, 2302, 10.1038/onc.2010.34 · DOI · Paper page
  48. Yang, 2009, T-bet is essential for encephalitogenicity of both Th1 and Th17 cells, J Exp Med, 206, 1549, 10.1084/jem.20082584 · DOI
  49. Zhang, 2009, MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a, J Mol Med, 87, 43, 10.1007/s00109-008-0403-6 · DOI · Paper page

Cited by

Sorted by citations

See all 188

Metadata

Authors
Guerau-de-Arellano, M., Smith, K. M., Godlewski, J., Liu, Y., Winger, R., Lawler, S. E., Whitacre, C. C., Racke, M. K., & Lovett-Racke, A. E.
Venue
Brain
Published
2011-11-15
Volume
134
Issue
12
Pages
3578-3589
ISSN
  • 1460-2156
  • 0006-8950
Cited by
188
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review